⚖ Oral Arguments, with Context

The D.C. Circuit reviews the revocation of Dr. Mark Huff's federal authority to prescribe controlled drugs. The dispute began when Huff sought to move his registration from Utah to Georgia, prompting a DEA investigation. The agency found that he had not been candid about a fentanyl relapse and subsequent treatment. Huff maintained that he had misunderstood questions about treatment. He requested an administrative hearing and submitted a brief description of his proposed testimony. The administrative law judge found that description inadequate and terminated the hearing proceedings. DEA's administrator then revoked Huff's registration. Huff will argue that his summary complied with the judge's order and that denying him a hearing was improper. DEA will defend the judge's authority to enforce procedural requirements. Listen for the difference between limiting testimony that was not disclosed in advance and denying a hearing altogether.

Mark Huff, M.D. v. Drug Enforcement Administration (No. 26-1029) — United States Court of Appeals for the District of Columbia Circuit, argued November 10, 2026.